Malfertheiner, Peter http://orcid.org/0000-0001-8439-9036
Camargo, M. Constanza
El-Omar, Emad http://orcid.org/0000-0002-0011-3924
Liou, Jyh-Ming http://orcid.org/0000-0002-7945-5408
Peek, Richard
Schulz, Christian http://orcid.org/0000-0003-1841-1337
Smith, Stella I.
Suerbaum, Sebastian
Article History
Accepted: 17 March 2023
First Online: 20 April 2023
Competing interests
: P.M. has consulted for Aboca, Bayer Healthcare, Cinclus, Imevax, Menarini Foundation and Phatom. P.M. has received honoraria for lectures from Allergosan, Biohit, Biocodex and Malesci. S.I.S. has received scientific support from Richen. C.S. has received speaker fees from Imevax, Falk Foundation and Lilly. S.S. is listed as an inventor on a patent application related to the use of bacterial motility inhibitors as potential treatment for <i>Helicobacter pylori</i> infection.
Free to read: This content has been made available to all.